Medicine · Research topic

Open research questions in Atrial Fibrillation Management and Outcomes

342 unresolved questions extracted from the limitations and future-work sections of 995 Atrial Fibrillation Management and Outcomes papers in our library. Each links back to the study that raised it.

What the literature leaves open

  • The study faces challenges in translating findings from a rat model to humans. The researchers need to control for various factors that may influence the relationship between exercise intensity and atrial fibrillation. There may be technical challenges in measuring atrial fibrillation and electrophysiological parameters in rats.

    Effects of different intensity endurance training on atrial fibrillation in rats · 2026 · DOI
  • Real-world inpatient bleeding data for DOACs is relatively sparse. Most evidence comes from randomized trials enrolling ambulatory patients, which may not reflect the risk profile of acutely ill inpatients. There is a need for descriptive, observational safety analyses of DOACs in real-world inpatient settings.

    Real-World Bleeding Outcomes Among Hospitalized Patients Receiving Apixaban or Rivaroxaban: A Single-Center Retrospective Cohort Study · 2026 · DOI
  • Evidence supporting specific regimens in this population remains limited and largely observational, - The proposed risk-stratified, time-dependent approach should be regarded as a pragmatic decision-support framework rather than a prescriptive treatment strategy, - Further prospective studies are needed to define the optimal antithrombotic management in this complex population

    Coronary Artery Disease and Atrial Fibrillation in HighBleeding Risk: Indications and Optimal Antithrombotic Therapy After Percutaneous Left Atrial Appendage Occlusion · 2026 · DOI
  • The retrospective nature of the study, which may introduce biases. The potential for multicollinearity among predictors, which was addressed by calculating variance inflation factors (VIF). The need to handle missing data, which was addressed through multiple imputation using the 'missRanger' package.

    Construction and validation of a predictive model for new-onset atrial fibrillation in patients with acute myocardial infarction following emergency percutaneous coronary intervention based on novel inflammatory markers · 2026 · DOI
  • further studies are needed to validate the nomogram, - comparison of the predictive effectiveness of different inflammatory markers, - investigation of the underlying mechanisms of NOAF

    Construction and validation of a predictive model for new-onset atrial fibrillation in patients with acute myocardial infarction following emergency percutaneous coronary intervention based on novel inflammatory markers · 2026 · DOI
  • the complex pathogenesis of AF and significant interindividual variability make it difficult to determine the specific causes in each patient, - clinical efficacy needs to be further improved, - intensive glycemic control failed to significantly reduce the risk of new-onset AF

    Glucose metabolic dysregulation of diabetes and Its role in atrial fibrillation pathogenesis · 2026 · DOI
  • investigating the role of HBP and O-GlcNAc modification in AF, - exploring the therapeutic potential of SGLT2 inhibitors and GLP-1 RAs for AF, - studying the effects of diabetes on cardiac metabolism and function

    Glucose metabolic dysregulation of diabetes and Its role in atrial fibrillation pathogenesis · 2026 · DOI
  • The study faced challenges in terms of patient selection and enrollment. The study required careful consideration of biomarker confounders, such as active infection or chronic inflammatory conditions. The study had to balance the need for comprehensive biomarker analysis with the potential for procedural complications.

    Biomarker response to balloon-in-basket pulsed field ablation: does posterior wall isolation matter? · 2026 · DOI
  • The study was a single-center study, - The sample size was limited to 60 patients, - The study did not investigate long-term outcomes

    Biomarker response to balloon-in-basket pulsed field ablation: does posterior wall isolation matter? · 2026 · DOI
  • Further studies are needed to explore the key molecular mechanisms involved in AngII-induced AF, - Research on the effects of anti-inflammatory treatments on AF incidence

    Inflammation pathways as therapeutic targets in angiotensin II induced atrial fibrillation · 2025 · DOI
  • Algorithm transparency and bias, - Data integration and regulatory hurdles, - Lack of explainability can hinder clinician trust and adoption, - Need for collaborative consortia and data-sharing with privacy protections

    Artificial intelligence in atrial fibrillation: emerging applications, research directions and ethical considerations · 2025 · DOI
  • Developing standardised, well-annotated datasets for AF, - Building large, shared databases of ECGs, patient outcomes, and imaging data, - Integrating various data modalities, - Combining multimodal data in AI models to yield new insights

    Artificial intelligence in atrial fibrillation: emerging applications, research directions and ethical considerations · 2025 · DOI
  • The paper identifies the complexity of atrial fibrillation as a challenge, with multiple factors contributing to its initiation and perpetuation. The limited robust clinical evidence for anti-inflammatory approaches is also a challenge. The paper notes that the bidirectional relationship between atrial fibrosis and inflammation is not fully understood, presenting a challenge for the development of effective therapeutic interventions.

    Interactions between atrial fibrosis and inflammation in atrial fibrillation · 2025 · DOI
  • Further investigation is needed to develop novel therapeutic interventions to enhance clinical management of AF, - The development of gender-specific therapeutic approaches may be beneficial, - More research is needed to understand the relationship between inflammation and AF

    Interactions between atrial fibrosis and inflammation in atrial fibrillation · 2025 · DOI
  • One challenge is the complex process of atrial fibrillation, which includes multiple factors such as atrial fibrosis, fatty infiltration, inflammation, ion channel dysfunction, atrial ischemia, and vascular remodeling. Another challenge is the limited understanding of the relationship between the electroanatomical atrial substrate and function through strain analysis. A technical challenge is the use of speckle-tracking echocardiography, which requires specialized equipment and expertise.

    Right atrial strain in atrial fibrillation: the hidden side of the moon · 2025 · DOI
  • The gap in the current literature is the poor characterization of right atrial alterations in atrial fibrillation. The gap in the current literature is the lack of understanding of the relationship between the electroanatomical atrial substrate and function through strain analysis. The gap in the current literature is the need for predictors of post-ablation AF recurrence.

    Right atrial strain in atrial fibrillation: the hidden side of the moon · 2025 · DOI
  • Further studies are needed to explore the mechanisms of immune infiltration in AF, - The role of lactylation in other diseases should be investigated, - The diagnostic model should be validated in larger human cohorts, - The effects of lactylation on atrial metabolite and immunity should be further studied

    Comprehensive analysis of lactylation-related gene and immune microenvironment in atrial fibrillation · 2025 · DOI
  • The mechanisms of immune infiltration in atrial fibrillation remain unclear. The association between lactylation and AF is unexplored. There is a need for therapeutic innovation in AF treatment.

    Comprehensive analysis of lactylation-related gene and immune microenvironment in atrial fibrillation · 2025 · DOI
  • The association between IBI and NOAF in STEMI patients is unclear. There is a need to establish a precise and effective risk stratification system for NOAF in STEMI patients. The study aims to fill this gap by exploring the predictive ability of IBI for NOAF.

    Predictive value of inflammatory burden index for new-onset atrial fibrillation in STEMI patients · 2025 · DOI
  • Accurately quantifying fibrosis persists as a challenge despite advancements in imaging. The heterogeneity of fibrosis leads to distinct electrophysiological abnormalities that promote AF. Dissolving pre-existing collagen deposits within atrial tissue remains a formidable challenge.

    Atrial Fibrosis in Atrial Fibrillation: Mechanistic Insights, Diagnostic Challenges, and Emerging Therapeutic Targets · 2024 · DOI
  • The precise mechanisms by which different types of fibrosis affect atrial conduction and arrhythmogenesis remain incompletely understood. Current imaging techniques lack standardization and spatial resolution sufficient to reliably quantify the extent and type of atrial fibrosis.

    Atrial Fibrosis in Atrial Fibrillation: Mechanistic Insights, Diagnostic Challenges, and Emerging Therapeutic Targets · 2024 · DOI
  • The efficacy of DOACs in preventing recurrent embolic stroke of unknown source remains uncertain. The timing of initiation of anticoagulation after acute ischemic stroke is debated.

    Cardioembolic Stroke: Past Advancements, Current Challenges, and Future Directions · 2024 · DOI
  • The relationship between low-intensity or moderate-intensity exercise and atrial fibrillation is not well understood. The potential mechanism linking exercise intensity to the susceptibility to atrial fibrillation is not fully explored. There is a need to investigate the effects of different intensity endurance training on atrial fibrillation in rats.

    Effects of different intensity endurance training on atrial fibrillation in rats · 2026 · DOI
  • further studies with systematic adjudication, - research on the impact of antiplatelet agent use, - studies with larger sample sizes

    Real-World Bleeding Outcomes Among Hospitalized Patients Receiving Apixaban or Rivaroxaban: A Single-Center Retrospective Cohort Study · 2026 · DOI
  • Whether CR, particularly when tailored for patients with obesity, is effective to reduce AF symptom burden remains uncertain [ 6 ].

    Effects on atrial fibrillation symptom burden of an obesity-focused cardiac rehabilitation program: Insights from the OPTICARE XL trial · 2026 · DOI

Most-cited papers in Atrial Fibrillation Management and Outcomes

Most recent work

Find a gap in your own Atrial Fibrillation Management and Outcomes sub-topic

This page shows what the Atrial Fibrillation Management and Outcomes literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.

Open the Research Gap Finder →

Related topics in Medicine

342 open questions have been extracted from the limitations and future-work passages of 995 Atrial Fibrillation Management and Outcomes papers in our library. Each one below links back to the study that raised it, so you can read the original claim in context.

Tools for your next paper

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.